Leuprolide Completed Phase 2 Trials for Melanoma Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00254397Melanoma Vaccine With Peptides and Leuprolide